Content about Osteoporosis

February 8, 2012

CVS/pharmacy announced on Wednesday the launch of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities.

WOONSOCKET, R.I. — CVS/pharmacy announced on Wednesday the launch of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities.

September 19, 2011

The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

THOUSAND OAKS, Calif. — The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

Amgen announced the approval of the biotech drug Prolia (denosumab) for increasing bone mass in men and women who are at risk of fractures due to hormone ablation treatments they are receiving for prostate and breast cancer, respectively.

September 15, 2011

Without magnesium, calcium supplements increase risk of heart attacks, according to a meta-analysis recently conducted by Carolyn Dean, medical director of the Nutritional Magnesium Association.

ORANGE, Calif. — Without magnesium, calcium supplements increase risk of heart attacks, according to a meta-analysis recently conducted by Carolyn Dean, medical director of the Nutritional Magnesium Association.

"If we consume too much calcium without sufficient magnesium, the excess calcium is not utilized correctly and may actually become toxic, causing painful conditions, such as some forms of arthritis, kidney stones, osteoporosis and calcification of the arteries leading to heart attack and cardiovascular disease," Dean said.

August 25, 2011

Amgen has launched an educational campaign that targets women with postmenopausal osteoporosis at increased risk for fractures.

THOUSAND OAKS, Calif. — Amgen has launched an educational campaign that targets women with postmenopausal osteoporosis at increased risk for fractures.

The drug maker said that to promote its Act 2 Reduce Fractures campaign, which is supported by American Bone Health, the Global Healthy Living Foundation and the Older Women's League, the company has tapped award-winning actress Blythe Danner, who was diagnosed with the disease, to encourage women to learn of the risk factors and ways to improve their condition.

August 10, 2011

Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

MIAMI — Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

June 1, 2011

Overweight or obese women who have less-than-optimal levels of vitamin D and lose more than 15% of their body weight experience significant increases in circulating levels of this fat-soluble nutrient, according to a study released last week by researchers at Fred Hutchinson Cancer Research Center.

SEATTLE — Overweight or obese women who have less-than-optimal levels of vitamin D and lose more than 15% of their body weight experience significant increases in circulating levels of this fat-soluble nutrient, according to a study released last week by researchers at Fred Hutchinson Cancer Research Center.

May 13, 2011

More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

WASHINGTON — More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

May 12, 2011

Japan-based Takeda Pharmaceutical may acquire Switzerland’s Nycomed for $12 billion, according to published reports.

NEW YORK — Japan-based Takeda Pharmaceutical may acquire Switzerland’s Nycomed for $12 billion, according to published reports.

Reuters reported Thursday that Takeda was in talks to buy Nycomed in order to expand its presence in the European market. Most of Takeda’s business is in Asia and the United States.

Nycomed makes treatments for such diseases as chronic obstructive pulmonary disease, chronic pain, osteoporosis and others.

April 25, 2011

CVS/pharmacy is taking its focus on preventive care to the streets with its 2011 To Your Health program, staging more than 800 events around the country and screening patients for diabetes, blood pressure, cholesterol, bone density and vision. Each To Your Health event offers customers access to as much as $150 worth of health screenings, as well as medical reviews with CVS pharmacists; consultations with doctors; dental and chiropractic screenings; and referrals for mammograms and pap smears in certain locations.


April 15, 2011

Abbott Diagnostics on Friday announced its filing of a submission for clearance by the Food and Drug Administration for a fully automated vitamin D assay performed on its Architect testing system for use by healthcare professionals.

ABBOTT PARK, Ill. — Abbott Diagnostics on Friday announced its filing of a submission for clearance by the Food and Drug Administration for a fully automated vitamin D assay performed on its Architect testing system for use by healthcare professionals.

"Increasing interest in vitamin D is fueling a surge in orders for tests as more healthcare professionals and consumers become aware of the rising prevalence of vitamin D deficiencies in otherwise healthy people and the potential health risks," stated Sudarshan Hebbar, senior medical director of Abbott Diagnostics.

March 18, 2011

Drug maker Eli Lilly is warning patients to avoid using alcohol prep pads that come with one of its osteoporosis drugs due to the risk of bacterial infections.

INDIANAPOLIS — Drug maker Eli Lilly is warning patients to avoid using alcohol prep pads that come with one of its osteoporosis drugs due to the risk of bacterial infections.

February 28, 2011

CVS/pharmacy has announced the launch of the 2011 To Your Health program, offering free preventive health screenings at more than 800 events in communities across the country. The program is designed to help Americans determine their risk for chronic diseases and get them on a path to better health.

WOONSOCKET, R.I. — CVS/pharmacy has announced the launch of the 2011 To Your Health program, offering free preventive health screenings at more than 800 events in communities across the country. The program is designed to help Americans determine their risk for chronic diseases and get them on a path to better health.

The program will get under way in Houston on March 5, and continue in Dallas, Los Angeles, Washington, D.C., Atlanta, Philadelphia, Chicago and Miami.

November 30, 2010

On the same day that the Institute of Medicine increased the daily recommended intake of vitamin D to maintain bone health, Pfizer Consumer Healthcare Tuesday announced the launch of Caltrate Soft Chews, which incorporate the higher daily recommended vitamin D goals.

MADISON, N.J. — On the same day that the Institute of Medicine increased the daily recommended intake of vitamin D to maintain bone health, Pfizer Consumer Healthcare Tuesday announced the launch of Caltrate Soft Chews, which incorporate the higher daily recommended vitamin D goals.

November 30, 2010

The Institute of Medicine on Tuesday issued a report on the dietary reference intake levels for vitamin D and calcium at the behest of both the U.S. and Canadian governments. IOM recommended a slight increase in vitamin D intake, but also suggested that the need for either vitamin D or calcium may be overstated.

WASHINGTON — The Institute of Medicine on Tuesday issued a report on the dietary reference intake levels for vitamin D and calcium at the behest of both the U.S. and Canadian governments. IOM recommended a slight increase in vitamin D intake, but also suggested that the need for either vitamin D or calcium may be overstated.

November 4, 2010

Biotech company Amgen took home a top award for one of its drugs at an...

THOUSAND OAKS, Calif. Biotech company Amgen took home a top award for one of its drugs at an annual event for drug makers, the company said Friday.

 

Amgen won the Best New Drug award for the osteoporosis treatment Prolia (denosumab) at the 2010 Scrip Awards in London Thursday.

 

The drug works by targeting the cells that break down bone, called osteoclasts, and was named one of the top 10 medical breakthroughs of 2009 in Time magazine.

October 11, 2010

The Food and Drug Administration has approved a new formulation of a drug for osteoporosis...

ARDEE, Ireland The Food and Drug Administration has approved a new formulation of a drug for osteoporosis made by Warner Chilcott, the drug maker said Monday.

 

Warner Chilcott announced the approval of Atelvia (risendronate sodium), a treatment for postmenopausal osteoporosis, which it plans to launch early next year. The drug is a delayed-release formulation of Actonel.

 

 

June 16, 2010

CVS/pharmacy is bringing its To Your Health community wellness program to the Philadelphia area starting...

June 9, 2010

CVS/pharmacy is bringing its To Your Health community wellness program to the Washington, D.C., area...

June 8, 2010

Unigene Labs has appointed a new leader, the company said Wednesday....

June 6, 2010

Matrixx Initiatives recently introduced a new line of Zicam products—Cold Remedy Plus—a multi-ingredient formulation that...

June 6, 2010

Welcome to the new “business as unusual” where shoppers have their sights set on health...

June 1, 2010

The Food and Drug Administration has approved a new drug from Amgen for osteoporosis, Amgen...

May 10, 2010

The International Osteoporosis Foundation on Monday released a new position statement around the importance of...

March 11, 2010

Analysis by the Food and Drug Administration has yet to establish a link between thigh-bone...

February 10, 2010

Women with Type 2 diabetes who take a commonly prescribed class of medications to treat...